Brown Gibbons Lang & Company Presents:
Meet with investors and industry participants for licensing, financing,
co-development, and M&A opportunities.
About DxPx U.S.
The DxPx Origin Story
- DxPx was established in 2019 in Dusseldorf, Germany by Dr. Mirko Stange, a scientist and entrepreneur.
- Despite being one of the fastest-growing disciplines in medicine, Diagnostics was vastly underrepresented at partnering conferences compared to other life sciences fields such as Therapeutics and Biotech.
- DxPx was founded to address this need in the market and facilitate connections between companies and investors in Diagnostics, Digital Health, Precision Medicine, and Life Science Tools.
The Next Phase of DxPx
- Brown Gibbons Lang & Company (BGL), a leading investment bank and financial advisory firm with deep experience in the life sciences industry, joined DxPx as a sponsor in its first year.
- By 2023, BGL had brought so many of its growth-stage company and private equity relationships to the conference that the firm became an official co-sponsor of DxPx’s first venture outside of the EU - DxPx U.S.
- BGL's expertise in capital formation, technology strategy, corporate ventures, and mergers & acquisitions brings a host of additional long-term value and opportunities to all DxPx participants.
DxPx in 2023 & Beyond
- In 2023, DxPx U.S. found a new home - within the ADLM Clinical Lab Expo (formerly AACC Clinical Lab Expo), the premier global laboratory medicine exposition.
- With over 900 exhibitors, including relevant strategic buyers, proximity to the ADLM 2024 Clinical Lab Expo offers incredible networking opportunities for DxPx U.S. attendees and unparalleled brand exposure for DxPx sponsors, exhibitors, and presenters.
- Companies who are exhibiting at ADLM can receive a free registration for DxPx, courtesy of ADLM’s Gold Sponsorship of DxPx U.S.
